Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin N Rome

Showing results (61-70 of 139) with videos related to

Pageof 14
Sort By:
JAMA Network Open|August 19, 2025
Benefits and Limitations of Direct-to-Consumer Pharmacies in the USHussain S Lalani, Aaron S Kesselheim, Benjamin N Rome
JAMA Health Forum|August 17, 2022
Medicare Spending on Drugs With Accelerated Approval, 2015-2019Benjamin N Rome, William B Feldman, Aaron S Kesselheim
Health Affairs (Project Hope)|June 5, 2023
Inflationary Rebates For Generic Drugs Sold Through Medicaid Saved Billions During 2017-20Benjamin N Rome, Aayan N Patel, Aaron S Kesselheim
The Milbank Quarterly|August 10, 2021
Pursuing Value-Based Prices for Drugs: A Comprehensive Comparison of State Prescription Drug-Pricing BoardsLiam Bendicksen, Benjamin N Rome, Jerry Avorn, et al.
Health Affairs (Project Hope)|January 20, 2017
Six-Month Market Exclusivity Extensions To Promote Research Offer Substantial Returns For Many Drug MakersAaron S Kesselheim, Benjamin N Rome, Ameet Sarpatwari, et al.
Health Affairs (Project Hope)|August 5, 2024
Biosimilar Uptake In The US: Patient And Prescriber FactorsDongzhe Hong, Aaron S Kesselheim, Ameet Sarpatwari, et al.
Clinical Pharmacology and Therapeutics|October 13, 2022
Patient Out-of-Pocket Costs Following the Availability of Biosimilar Versions of InfliximabKimberly Feng, Aaron S Kesselheim, Massimiliano Russo, et al.
JAMA Dermatology|April 16, 2025
Use and Cost of First-Line Biologic Medications to Treat Plaque Psoriasis in the USBenjamin N Rome, Jihye Han, Helen Mooney, et al.
American Heart Journal|December 28, 2020
Non-warfarin oral anticoagulant copayments and adherence in atrial fibrillation: A population-based cohort studyBenjamin N Rome, Joshua J Gagne, Jerry Avorn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 11, 2022
Indication-Specific Generic Uptake of Imatinib Demonstrates the Impact of Skinny LabelingBryan S Walsh, Aaron S Kesselheim, Ameet Sarpatwari, et al.
Pageof 14

Showing results (61-70 of 139) with videos related to

Sort By:
Pageof 14
JAMA Network Open|August 19, 2025
Benefits and Limitations of Direct-to-Consumer Pharmacies in the USHussain S Lalani, Aaron S Kesselheim, Benjamin N Rome
JAMA Health Forum|August 17, 2022
Medicare Spending on Drugs With Accelerated Approval, 2015-2019Benjamin N Rome, William B Feldman, Aaron S Kesselheim
Health Affairs (Project Hope)|June 5, 2023
Inflationary Rebates For Generic Drugs Sold Through Medicaid Saved Billions During 2017-20Benjamin N Rome, Aayan N Patel, Aaron S Kesselheim
The Milbank Quarterly|August 10, 2021
Pursuing Value-Based Prices for Drugs: A Comprehensive Comparison of State Prescription Drug-Pricing BoardsLiam Bendicksen, Benjamin N Rome, Jerry Avorn, et al.
Health Affairs (Project Hope)|January 20, 2017
Six-Month Market Exclusivity Extensions To Promote Research Offer Substantial Returns For Many Drug MakersAaron S Kesselheim, Benjamin N Rome, Ameet Sarpatwari, et al.
Health Affairs (Project Hope)|August 5, 2024
Biosimilar Uptake In The US: Patient And Prescriber FactorsDongzhe Hong, Aaron S Kesselheim, Ameet Sarpatwari, et al.
Clinical Pharmacology and Therapeutics|October 13, 2022
Patient Out-of-Pocket Costs Following the Availability of Biosimilar Versions of InfliximabKimberly Feng, Aaron S Kesselheim, Massimiliano Russo, et al.
JAMA Dermatology|April 16, 2025
Use and Cost of First-Line Biologic Medications to Treat Plaque Psoriasis in the USBenjamin N Rome, Jihye Han, Helen Mooney, et al.
American Heart Journal|December 28, 2020
Non-warfarin oral anticoagulant copayments and adherence in atrial fibrillation: A population-based cohort studyBenjamin N Rome, Joshua J Gagne, Jerry Avorn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 11, 2022
Indication-Specific Generic Uptake of Imatinib Demonstrates the Impact of Skinny LabelingBryan S Walsh, Aaron S Kesselheim, Ameet Sarpatwari, et al.
Pageof 14